title: Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge.
authors.affiliation: MUSC Dept. of Surgery, Charleston, South Carolina, 29425, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Cole
authors.forename: M C
authors.initials: MC
authors.lastname: Wilson
authors.forename: P L
authors.initials: PL
authors.lastname: Baron
authors.forename: P
authors.initials: P
authors.lastname: O'Brien
authors.forename: C
authors.initials: C
authors.lastname: Reed
authors.forename: K Y
authors.initials: KY
authors.lastname: Tsang
authors.forename: J
authors.initials: J
authors.lastname: Schlom
mesh_terms: D000230:Adenocarcinoma / Q000517:prevention & control*; D000328:Adult; D000368:Aged; D000818:Animals; D001943:Breast Neoplasms / Q000517:prevention & control*; D002272:Carcinoembryonic Antigen / Q000235:genetics / Q000276:immunology*; D002985:Clinical Protocols; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000517:prevention & control*; D005822:Genetic Vectors; D006801:Humans; D008175:Lung Neoplasms / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D010455:Peptides; D014611:Vaccination; D014614:Vaccines, Synthetic; D014616:Vaccinia virus / Q000235:genetics*; D014765:Viral Vaccines
chemical_list: D002272:Carcinoembryonic Antigen; D010455:Peptides; D014614:Vaccines, Synthetic; D014765:Viral Vaccines